(Trial in progress) A real-life prospective, observational, post-authorisation safety study in adult breast cancer patients treated with neratinib in extended adjuvant in Europe: the NERLYFE study

• R. Valenti,
• C. Plantet,
• A. Tadmouri

Affiliations

R. Valenti

C. Plantet

A. Tadmouri